AGR Assura Plc

7 October 2024

Assura plc

Scrip Dividend Declaration

Assura plc ("Assura" or "the Company"), the diversified healthcare REIT, today announces that, pursuant to its Scrip Dividend Scheme and in response to the scrip dividend alternative for the quarterly interim dividend payable on 9 October 2024 (the "Scrip Dividend Alternative"), elections were received in respect of 22.1 per cent. of the Company's ordinary shares in issue as at the record date of 6 September 2024.

Electing shareholders will receive ordinary shares in the Company ("Shares") in lieu of cash in respect of this dividend and, accordingly 13,657,643 Shares (the "New Shares") will be issued by the Company to such shareholders.

Application has therefore been made for the admission of the New Shares to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 9 October 2024.

Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 3,250,608,887 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 3,250,608,887.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (https://data.fca.org.uk/#/nsm/nationalstoragemechanism).

This interim dividend is 100% Property Income Distribution ("PID"). Forms to register for gross PIDs (on future interim dividends) are available on the Company's website. Please click here for PID Forms.

- ENDS -

For more information, please contact:

Notes to Editors

Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

Assura plc LEI code: 21380026T19N2Y52XF72

*EPRA is a registered trademark of the European Public Real Estate Association.